Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2014
08/28/2014US20140242151 Adhesive skin patch
08/28/2014US20140242150 Therapeutic compositions and methods of treatment with capsianoside-type compounds
08/28/2014US20140242147 Adsorbents for oral administration
08/28/2014US20140242139 Controlled drug delivery
08/28/2014US20140242119 Amino alcohol derivatives for the treatment of demyelinating peripheral neuropathies
08/28/2014US20140242112 Novel vaccine
08/28/2014US20140242109 Method for cultivating alga and method for producing alginic acid-containing composition
08/28/2014US20140242099 Compounds for inflammation and immune-related uses
08/28/2014US20140242097 Methods
08/28/2014US20140242091 Method for treating pathologies associated with hypoxia using mif inhibitors
08/28/2014US20140242088 Hsp90 inhibitor combinations
08/28/2014US20140242082 Combination therapy for the treatment of ocular neovascular disorders
08/28/2014US20140242078 Methods and monitoring of treatment with a wnt pathway inhibitor
08/28/2014US20140242071 M-csf specific monoclonal antibody and uses thereof
08/28/2014US20140242069 KRT19 Stabilizing HER2 and Use thereof
08/28/2014US20140242067 Treatment of central nervous system disorders by intranasal administration of immunoglobulin g
08/28/2014US20140242063 Pharmaceutical compositions
08/28/2014US20140242055 Compositions containing non-polar compounds
08/28/2014US20140242054 Methods and compositions for treating respiratory conditions using platelet enriched plasma
08/28/2014US20140242051 Probiotic, Lactic Acid-Producing Bacteria and Uses Thereof
08/28/2014US20140242037 Apc-mediated tolerance induction for therapy of multiple sclerosis
08/28/2014US20140242035 Methods and systems for treating cell proliferation disorders
08/28/2014US20140242030 Novel anti-hcv agent
08/28/2014US20140242029 Combination therapy for treating hcv infection in an hcv-hiv coinfected patient population
08/28/2014US20140242028 Antiviral compounds
08/28/2014US20140242027 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
08/28/2014US20140242026 Compounds, compositions, and methods for preventing metastasis of cancer cells
08/28/2014US20140242022 Compositions for the treatement of dry eye
08/28/2014US20140242020 Ginger Extract for the Protection of Stem Cells
08/28/2014US20140242018 Liquid non-ionic salt-free skin and hair treatment composition that contains n-methyl lauroyl glucamide
08/28/2014US20140242012 Methods for treating uv-damaged skin and scc tumors and for removing tattoos with topical ingenol mebutate
08/28/2014US20140242010 Method And Compositions For Treating Skin
08/28/2014US20140241996 Therapeutic nanoparticles and methods of use thereof
08/28/2014US20140241990 Methods of using adenosine a1 receptor activation for treating depression
08/28/2014US20140241988 Methods and compositions for treating atrial fibrillation
08/28/2014US20140241983 Methods and Compositions for Enhancing the Therapeutic Effect of Anti-Tumor T Cells
08/28/2014US20140239526 Process for producing pellets for pharmaceutical compositions
08/28/2014US20140238412 Methods for treating obstructive sleep apnea
08/28/2014DE112012005185T5 Transdermales Verabreichungssystem The transdermal delivery system
08/28/2014DE102013003517A1 Katheter, insbesondere zur Behandlung von Prostata und/oder Blase, und diesen Katheter enthaltendes Kit Catheter, in particular for the treatment of prostate and / or bladder, and this catheter kit containing
08/27/2014EP2769980A1 Pyrazoloquinoline derivative
08/27/2014EP2769976A1 Hydroxamic acid compound containing quinolyl and preparation method thereof, and pharmaceutical composition containing this compound and use thereof
08/27/2014EP2769974A1 Novel AMPK activator
08/27/2014EP2769973A2 Ingenane-type diterpene compound, and pharmaceutical composition for treating or preventing viral infectious diseases containing same
08/27/2014EP2769738A1 Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists
08/27/2014EP2769737A1 Combination of an anti-CTLA4 antibody with etoposide for the synergistic treatment of proliferative diseases
08/27/2014EP2769736A1 Pharmaceutical composition for the treatment of burnout syndrome
08/27/2014EP2769729A1 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
08/27/2014EP2769728A1 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
08/27/2014EP2769727A1 Use for deoxynucleoside/nucleoside combination in preparation of tumor medicament
08/27/2014EP2769726A1 Synthetic or recombinant fucosylated Oligosaccarides for use in the treatment of infections
08/27/2014EP2769725A1 Compositions for use in alleviating symptoms associated with premenstrual syndrome and premenstrual dysphoric disorder
08/27/2014EP2769724A1 Inhibitors of Na(v) 1.9 channel activity and uses thereof for treating pain
08/27/2014EP2769723A1 Compounds for use in inhibiting HIV capsid assembly
08/27/2014EP2769722A1 Compounds for use in inhibiting HIV capsid assembly
08/27/2014EP2769721A2 Process for the preparation of substituted pyrimidine derivatives
08/27/2014EP2769720A1 Heterocyclic gsk-3 allosteric modulators
08/27/2014EP2769719A1 Formulations of radioprotective alpha, beta unsaturated aryl sulfones
08/27/2014EP2769718A1 Medicinal composition
08/27/2014EP2769717A1 A composition comprising reduced glutathione and acetaminophen and preparation method thereof
08/27/2014EP2769716A1 Pharmaceutical composition comprising fluoxetine as an active ingredient, for preventing or treating blood-brain barrier disorders
08/27/2014EP2769715A2 Methods for treating autoimmune disorders, and reagents related thereto
08/27/2014EP2769714A1 Transdermal therapeutic system for administering the active substance buprenorphine
08/27/2014EP2769713A1 Solid oral composition comprising a S1P receptor agonist and a sugar alcohol
08/27/2014EP2769712A1 Pharmaceutical formulation comprising DPP-IV inhibitor agglomerates and DPP-IV inhibitor particles
08/27/2014EP2768960A1 Glucagon binding nucleic acids
08/27/2014EP2768959A2 Compounds for treatment of ischemic injury
08/27/2014EP2768849A1 Novel plant defensins and use in the treatment of proliferative diseases
08/27/2014EP2768841A1 Acid addition salts of 5beta -hydroxy-6alpha -[2-(1h-imidazol-4-yl)ethylamino]cholestan-3beta -ol
08/27/2014EP2768840A1 Anti-diabetic aminosteroid derivatives
08/27/2014EP2768838A1 Substituted 3',5'-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections
08/27/2014EP2768832A1 Novel substituted imidazopyrimidines as gpbar1 receptor modulators
08/27/2014EP2768831A1 A compound for the treatment of hepatitis c
08/27/2014EP2768829A1 Microbiocidal pyrazole derivatives
08/27/2014EP2768826A1 Substituted oxadiazolyl pyridinones and oxadiazolyl pyridazinones as hif inhibitors
08/27/2014EP2768824A2 Hybrid diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer
08/27/2014EP2768823A1 2-pyridyloxy-4-nitrile orexin receptor antagonists
08/27/2014EP2768822A2 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
08/27/2014EP2768821A1 Solid forms of 1,l-dioxo-4-thiomorpholinyl)-[6-[[3(4-fluorophenyl)-5-methyl-4-isoxazolyl]methoxy]-3-pyridinyl]-methanone
08/27/2014EP2768820A2 A process for making an intermediate of cabazitaxel
08/27/2014EP2768814A1 Novel non-steroidal compounds as androgen receptor modulators
08/27/2014EP2768813A1 Quinazoline derivatives as pi3k modulators
08/27/2014EP2768812A1 Acid addition salts of bosentan
08/27/2014EP2768810A1 Compounds that modulate intracellular calcium
08/27/2014EP2768809A1 Pyridine- sulfoximines as tyrosine kinase inhibitors
08/27/2014EP2768803A1 2-methylene-vitamin d analogs and their uses
08/27/2014EP2768799A1 Substituted biaryl alkyl amides
08/27/2014EP2768798A1 Novel phenicol antibacterials
08/27/2014EP2768797A1 Novel modified curcumins and their uses
08/27/2014EP2768537A2 Acrylic polymer formulations
08/27/2014EP2768513A2 Use of avermectin derivative for increasing bioavailability and efficacy of macrocylic lactones
08/27/2014EP2768512A1 Enzyme inhibitor for cancer treatment
08/27/2014EP2768511A1 Improvements in or relating to organic compounds
08/27/2014EP2768510A1 Camalexin as a treatment for prostate cancer
08/27/2014EP2768509A1 Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
08/27/2014EP2768508A1 Solution for oral administration
08/27/2014EP2768507A2 Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment
08/27/2014EP2768506A2 Compounds and methods for enhancing innate immune responses
08/27/2014EP2768505A1 New salt and medical use
08/27/2014EP2768504A1 Compositions for controlling vascularization in ophthalmological and dermatological diseases
1 ... 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 ... 7860